000 01884cam  2200373zi 4500
0019.883227
003CaOODSP
00520221107170515
006m     o  d f      
007cr |n|||||||||
008191231t20202020onc     ob   f|0| 0 eng d
020 |a9780660336589
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH14-342/2020E-PDF
24510|aAnnex 3B to the good manufacturing practices guide : |bpositron-emitting radiopharmaceuticals (GUI-0071).
264 1|a[Ottawa] : |bHealth Canada = Santé Canada, |c2020.
264 4|c©2020
300 |a1 online resource (34 pages)
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Annexe 3B aux Lignes directrices sur les Bonnes pratiques de fabrication : produits radiopharmaceutiques émetteurs de positrons.
500 |aIssued also in HTML format.
500 |a"September 15, 2020."
500 |a"Replaces: Annex to the Good Manufacturing Practices Guidelines Good Manufacturing Practices (GMP) for Positron Emitting Radiopharmaceuticals (PERs) (GUI-0071), February 15, 2006."
504 |aIncludes bibliographical references (pages 33-34).
650 0|aDrug factories|zCanada.
650 0|aRadiopharmaceuticals|zCanada.
7101 |aCanada. |bHealth Canada, |eissuing body.
77508|tAnnexe 3B aux Lignes directrices sur les bonnes pratiques de fabrication : |w(CaOODSP)9.883229
85640|qPDF|s1.45 MB|uhttps://publications.gc.ca/collections/collection_2021/sc-hc/H14-342-2020-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/guidance-documents/annex-manufacturing-practices-positiron-emitting-radiopharmaceuticals/document.html